Sort
39,280 grants matching “leukemia”
Therapeutic enzyme depletion of L-serine for cancer treatment
$605,654Everett Stone · University Of Texas At Austin · R01 · FY2025 · CA
Modeling and Predicting Therapeutic Resistance of Cancer
$605,631Dean W Felsher · Stanford University · U01 · FY2018 · CA
Phenotype-Genotype Associations with Symptoms During Childhood Leukemia Treatment
$605,604Marilyn J Hockenberry · Duke University · R01 · FY2015 · CA
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
$605,565Michael J Borowitz · Johns Hopkins University · R01 · FY2006 · CA
Molecular Digital CytoImaging for Leukemia Drug Screening
$605,517Tothu Q Vu · Oregon Health & Science University · R01 · FY2018 · CA
Lnk Regulatory Functions in Hematopoietic Stem Cells
$605,461Wei Tong · Children'S Hosp Of Philadelphia · R01 · FY2021 · HL
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
$605,322Kirsten Kimberlie Ness · St. Jude Children'S Research Hospital · R01 · FY2012 · CA
Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)
$605,310William L. Carroll · New York University School Of Medicine · R01 · FY2010 · CA
Predicting clinical outcome in individuals with small CLL B cell clones
$605,286Neil E Kay · Mayo Clinic Rochester · R01 · FY2017 · CA
Discovery of New Therapeutic Targets in ALL
$605,214Gary L. Gilliland · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Dynamic 3D chromatin remodeling in acute leukemia - Resubmission - 1
$605,184Aristotelis Tsirigos · New York University School Of Medicine · R01 · FY2023 · CA
Dynamic 3D chromatin remodeling in acute leukemia - Resubmission - 1
$605,181Aristotelis Tsirigos · New York University School Of Medicine · R01 · FY2022 · CA
Therapy-related leukemia following autologous transplantation for lymphoma
$604,943Smita Bhatia · Beckman Research Institute/City Of Hope · P50 · FY2021 · CA
Regulation of FLT3 Signaling in Leukemia
$604,938Wei Tong · Children'S Hosp Of Philadelphia · R01 · FY2024 · CA
Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT
$604,938Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2023 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP--WISCONSIN STUDIES
$604,916University Of Wisconsin Madison · U10 · FY2002 · CA
BCAP regulation of TLR7/9 signaling in Lupus
$604,865Jessica A Hamerman · Benaroya Research Inst At Virginia Mason · R01 · FY2024 · AI
Botswana Birth Outcomes Surveillance Extension
$604,783Roger L Shapiro · Harvard School Of Public Health · R01 · FY2020 · HD
Deconvoluting CAR T cell heterogeneity to engineer durable antitumor protection
$604,627Yina Hsing Huang · Dartmouth College · R01 · FY2025 · CA
GENETICS AND MECHANISMS OF DLI EFFECTS FOLLOWING NON-MYELOBLATIVE HCT
$604,606David H Sachs · Massachusetts General Hospital · P01 · FY2009 · CA
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect
$604,596Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL
Analysis of RNA binding proteins directing hematopoietic stem cell fate
$604,559Eugene Wei-Ming Yeo · University Of California, San Diego · R01 · FY2021 · HL
Project 3: Gene Therapy for Correction of Blood Disorders
$604,529Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · P01 · FY2019 · HL
Genomics of Acute myelogenous leukemia (AML): Whole Genome Resequencing
$604,378Richard K. Wilson · Washington University · P01 · FY2010 · CA
Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy
$604,357A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2010 · CA